Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.18 HKD | 0.00% | +7.27% | +12.38% |
Mar. 28 | SANVO Fine Chemicals Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | SANVO Fine Chemicals Awards Over 2.1 Million Shares to Employees | MT |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Capitalization 1 | 345.4 | 449.3 | 468.2 | 448.8 |
Enterprise Value (EV) 1 | 450.7 | 629.1 | 626.5 | 641.4 |
P/E ratio | 5.2 x | 32.1 x | 104 x | 72.9 x |
Yield | 3.13% | 2.32% | - | - |
Capitalization / Revenue | 0.41 x | 0.46 x | 0.49 x | 0.42 x |
EV / Revenue | 0.54 x | 0.64 x | 0.66 x | 0.6 x |
EV / EBITDA | 5.33 x | 21.9 x | 30.3 x | 28.4 x |
EV / FCF | -6 x | 62.1 x | 15.8 x | -20.6 x |
FCF Yield | -16.7% | 1.61% | 6.34% | -4.86% |
Price to Book | 1.52 x | 1.93 x | 2.11 x | 1.94 x |
Nbr of stocks (in thousands) | 470,250 | 470,250 | 470,250 | 470,250 |
Reference price 2 | 0.7345 | 0.9556 | 0.9956 | 0.9544 |
Announcement Date | 4/23/21 | 3/28/22 | 3/28/23 | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 769.2 | 814 | 840 | 983.1 | 947.8 | 1,077 |
EBITDA 1 | 39.99 | 50.46 | 84.5 | 28.77 | 20.71 | 22.6 |
EBIT 1 | 33.84 | 41.55 | 74.7 | 18 | 10.98 | 11.86 |
Operating Margin | 4.4% | 5.1% | 8.89% | 1.83% | 1.16% | 1.1% |
Earnings before Tax (EBT) 1 | 27.53 | 26.72 | 73.66 | 15.81 | 9.067 | 11.53 |
Net income 1 | 24.33 | 23.94 | 65.82 | 14.02 | 4.492 | 6.214 |
Net margin | 3.16% | 2.94% | 7.84% | 1.43% | 0.47% | 0.58% |
EPS | - | 0.0645 | 0.1412 | 0.0298 | 0.009552 | 0.0131 |
Free Cash Flow 1 | 140.8 | -58.7 | -75.1 | 10.13 | 39.7 | -31.2 |
FCF margin | 18.31% | -7.21% | -8.94% | 1.03% | 4.19% | -2.9% |
FCF Conversion (EBITDA) | 352.18% | - | - | 35.22% | 191.71% | - |
FCF Conversion (Net income) | 578.75% | - | - | 72.31% | 883.85% | - |
Dividend per Share | - | 0.0195 | 0.0230 | 0.0222 | - | - |
Announcement Date | 12/27/19 | 4/28/20 | 4/23/21 | 3/28/22 | 3/28/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 76.1 | 114 | 105 | 180 | 158 | 193 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 1.903 x | 2.257 x | 1.246 x | 6.249 x | 7.647 x | 8.524 x |
Free Cash Flow 1 | 141 | -58.7 | -75.1 | 10.1 | 39.7 | -31.2 |
ROE (net income / shareholders' equity) | 41.8% | 42.6% | 42.3% | 6.1% | 1.98% | 2.76% |
ROA (Net income/ Total Assets) | 5.72% | 6.88% | 8.69% | 1.63% | 0.91% | 0.95% |
Assets 1 | 425.7 | 348 | 757.8 | 861.6 | 493.3 | 654.9 |
Book Value Per Share | - | 0.2300 | 0.4800 | 0.4900 | 0.4700 | 0.4900 |
Cash Flow per Share | - | 0.0400 | 0.1600 | 0.0400 | 0.1900 | 0.0800 |
Capex 1 | 30.7 | 33.8 | 98.8 | 57.9 | 39.9 | 38 |
Capex / Sales | 3.99% | 4.16% | 11.76% | 5.89% | 4.21% | 3.53% |
Announcement Date | 12/27/19 | 4/28/20 | 4/23/21 | 3/28/22 | 3/28/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+12.38% | 70.93M | |
+13.61% | 64.32B | |
-3.80% | 45.95B | |
+13.69% | 39.61B | |
+20.84% | 25.74B | |
+8.66% | 18.75B | |
+0.38% | 17.23B | |
-21.03% | 15.86B | |
+0.86% | 15.03B | |
-14.23% | 13.99B |
- Stock Market
- Equities
- 301 Stock
- Financials SANVO Fine Chemicals Group Limited